Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3082958

NC(=O)c1ccc(S(N)(=O)=O)cc1C1=CCCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.44
CSF1R P07333 3/20 0.43
ACMSD Q8TDX5 2/20 0.38
CA12 O43570 5/20 0.37
CA1 P00915 5/20 0.37
CA2 P00918 5/20 0.37
CA9 Q16790 4/20 0.37
CA7 P43166 2/20 0.37
GRM2 Q14416 1/20 0.37
IKBKB O14920 3/20 0.35
CHUK O15111 2/20 0.35
CA14 Q9ULX7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
EGFR P00533 1/20 0.33
FGFR1 P11362 1/20 0.33
SRC P12931 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3082964 0.86 PTGS2 (0.46) PTGS2CSF1RACMSDCA12CA1
Trifluoroacetic Acid SCHEMBL3083545 0.83 CSF1R (0.47) PTGS2CSF1RACMSDGRM2
SCHEMBL3082962 0.77 CSF1R (0.57) PTGS2CSF1RCA12CA1CA2
Trifluoroacetic Acid SCHEMBL2176880 0.75 CSF1R (0.47) CSF1RACMSDGRM2CYP2C9
Trifluoroacetic Acid SCHEMBL2907598 0.75 CSF1R (0.56) CSF1RCYP2C9
Trifluoroacetic Acid SCHEMBL5651777 0.74 CSF1R (0.57) CSF1RACMSDGRM2CYP2C9
SCHEMBL3076858 0.73 CSF1R (0.48) CSF1RACMSDGRM2
SCHEMBL3093846 0.73 CSF1R (0.54) CSF1RALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL2177840 0.73 CSF1R (0.49) CSF1RGRM2CYP2C9
Trifluoroacetic Acid SCHEMBL2178216 0.72 CSF1R (0.49) CSF1RCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US claimed
US-20060258666-A1 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-16 US claimed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US disclosed
US-20060258666-A1 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258666-A1 c-fms kinase inhibitors FLT3, FES, FER PTGS2 3654/4885CSF1R 111/4885ACMSD 4123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.